Review: Mineralization of synthetic polymer scaffolds for bone tissue engineering

Tissue Engineering

Volumn 13, Issue 5, 2007, Pages 927-938

  Kretlow, James D ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMIMETICS; BIOPOLYMERS; BONE; DRUG DELIVERY; GRAFTS; PHOSPHORUS;

BONE TISSUE ENGINEERING; MINERALIZATION; SYNTHETIC POLYMERS;

TISSUE ENGINEERING;

BIOMATERIAL; CALCIUM PHOSPHATE; PHOSPHORUS; POLYMER;

AUTOGRAFT; BIOMIMETICS; BONE ALLOGRAFT; BONE GRAFT; BONE TISSUE; DEMINERALIZATION; DRUG DELIVERY SYSTEM; MINERALIZATION; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; BIOMIMETIC MATERIALS; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; CALCIFICATION, PHYSIOLOGIC; DRUG DELIVERY SYSTEMS; HUMANS; POLYMERS; TISSUE ENGINEERING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34249889877     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0394     Document Type: Review

References (153)

1. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
2. Senn, N. On the healing of aseptic bone cavities by implantation of antiseptic decalcified bone. Am J Med Sci 98, 219, 1889.
3. Urist, M.R. Bone: formation by autoinduction. Science 150, 893, 1965.
4. Hacker, M.C., and Mikos, A.G. Trends in tissue engineering research. Tissue Eng 12, 2049, 2006.
5. HCUP Nationwide Inpatient Sample (NIS). Rockville, MD: Healthcare Cost and Utilization Project (HCUP): Agency for Healthcare Research and Quality, 2004.
6. Kessler, P., Thorwarth, M., Bloch-Birkholz, A., Nkenke, E., and Neukam, F.W. Harvesting of bone from the iliac crest - comparison of the anterior and posterior sites. Br J Oral Maxillofac Surg 43, 51, 2005.
7. Pacifico, M.D., Floyd, D., and Wood, S.H. Tibial stress fracture as a complication of free-fibula vascularised graft for mandibular reconstruction. Br J Plast Surg 56, 832, 2003.
8. Silber, J.S., Anderson, D.G., Daffner, S.D., Brislin, B.T., Leland, J.M., Hilibrand, A.S., Vaccaro, A.R., and Albert, T.J. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 28, 134, 2003.
9. Heary, R.F., Schlenk, R.P., Sacchieri, T.A., Barone, D., and Brotea, C. Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery 50, 510, 2002.
10. Zimmermann, C., Borner, B., Hasse, A., and Sieg, P. Donor site morbidity after microvascular fibula transfer. Clin Oral Investig 5, 214, 2001.
11. Hierholzer, C., Sama, D., Toro, J.B., Peterson, M., and Helfet, D.L. Plate fixation of ununited humeral shaft fractures: effect of type of bone graft on healing. J Bone Joint Surg Am 88, 1442, 2006.
12. Rogers, S.N., Lakshmiah, S.R., Narayan, B., Lowe, D.M., Brownson, P., Brown, J.S., and Vaughan, E.D. A comparison of the long-term morbidity following deep circumflex iliac and fibula free flaps for reconstruction following head and neck cancer. Plast Reconstr Surg 112, 1517, 2003.
13. Muscolo, D.L., Ayerza, M.A., Aponte-Tinao, L.A., and Ranalletta, M. Use of distal femoral osteoarticular allografts in limb salvage surgery. Surgical technique. J Bone Joint Surg Am 88, 305, 2006.
14. Ayerza, M.A., Aponte-Tinao, L.A., Abalo, E., and Muscolo, D.L. Continuity and function of patellar tendon host-donor suture in tibial allograft. Clin Orthop Relat Res 450, 33, 2006.
15. Johari, A., Shingade, V., Lobo Gajiwala, A., Shah, V., and D' Lima, C. The use of irradiated allograft in a paediatric population: an Indian experience. Cell Tissue Bank 2006 Jun 28; [Epub ahead of print].
16. Buck, B.E., Malinin, T.I., and Brown, M.D. Bone transplantation and human immunodeficiency virus: an estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res 240, 129, 1989.
17. Moreau, M.F., Gallois, Y., Basle, M.-F., and Chappard, D. Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells. Biomaterials 21, 369, 2000.
18. Lewandrowski, K.U., Rebmann, V., Passler, M., Schollmeier, G., Ekkernkamp, A., Grosse-Wilde, H., and Tomford, W.W. immune response to perforated and partially demineralized bone allografts. J Orthop Sci 6, 545, 2001.
19. Butler D. Last chance to stop and think on risks of xenotransplants. Nature 391, 320, 1998.
20. Albrektsson, T., and Johansson, C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 10, S96, 2001.
21. Kubler, N., Michel, C., Zoller, J., Bill, J., Muhling, J., and Reuther, J. Repair of human skull defects using osteoinductive bone alloimplants. J Craniomaxillofac Surg 23, 337, 1995.
22. Mulliken, J.B., Glowacki, J., Kaban, L.B., Folkman, J., and Murray, J.E. Use of Demineralized allogeneic bone implants for the correction of maxillocraniofacial deformities. Ann Surg 194, 366, 1981.
23. Vandersteenhoven, J.J., and Spector, M. Histological investigation of bone induction by demineralized allogeneic bone matrix: a natural biomaterial for osseous reconstruction. J Biomed Mater Res 17, 1003, 1983.
24. Hagino, T., and Hamada, Y. Accelerating bone formation and earlier healing after using demineralized bone matrix for limb lengthening in rabbits. J Orthop Res 17, 232, 1999.
25. Pietrzak, W.S., Perns, S.V., Keyes, J., Woodell-May, J., and McDonald, N.M. Demineralized bone matrix graft: a scientific and clinical case study assessment. J Foot Ankle Surg 44, 345, 2005.
26. Peterson, B., Whang, P.G., Iglesias, R., Wang, J.C., and Lieberman, J.R. Osteoinductivity of Commercially available demineralized bone matrix, preparations in a spine fusion model. J Bone Joint Surg Am 86, 2243, 2004.
27. Piattelli, A., Scarano, A., Corigliano, M., and Piattelli, M. Comparison of bone regeneration with the use of mineralized and demineralized freeze-dried bone allografts: a histological and histochemical study in man. Biomaierials 17, 1127, 1996.
28. Mauney, J.R., Jaquiery, C., Volloch, V., Heberer, M., Martin, I., and Kaplan, D.L. In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 26, 3173, 2005.
29. Glowacki, J., Altobelli, D., and Mulliken, J.B. Fate of mineralized and demineralized osseous implants in cranial defects. Calcif Tissue Int 33, 71, 1981.
30. Zhang, M., Ralph M. Powers, J., and Lloyd Wolfinbarger, J. A quantitative assessment of osteinductivity of human demineralized bone matrix. J Periodontol 68, 1076, 1997.
31. Zhang, M., Ralph M. Powers, J., and Lloyd Wolfinbarger, J. Effect(s) of the demineralization process on the osteinductivity of demineralized bone matrix. J Periodontol 68, 1085, 1997.
32. Pazzaglia, U.E., Zatti, G., Ragni, P., and Ceciliani, L. The role of mineralization in experimental models of osteogenic induction with decalcified bone matrix. Ital J Orthop Traumatol 14, 369, 1988.
33. Pietrzak, W.S.P. The hydration characteristics of demineralized and nondemineralized allograft bone: scientific perspectives on graft function. J Craniofac Surg 17, 120, 2006.
34. Hopp, S.G., Dahners, L.E., and Gilbert, J.A. Study of the mechanical strength of long bone defects treated with various bone autograft substitutes: an experimental investigation in the rabbit. J Orthop Res 7, 579, 1989.
35. Lewandrowski, K.-U., Tomford, W.W., Schomacker, K.T., Deutsch, T.F., and Mankin, H.J. Improved osteoinduction of cortical bone allografts: a study of the effects of laser perforation and partial demineralization. J Orthop Res 15, 748, 1997.
36. Reddi, A.H., and Anderson, W.A. Collagenous bone matrix-induced endochondral ossification and hemopoiesis. J Cell Biol 69, 557, 1976.
37. Johnson, E.E., Urist, M.R., and Finerman, G.A.M. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions: a preliminary report. Clin Orthop Relat Res 230, 257, 1988.
38. Reddi, A.H., and Cunningham, N.S. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8, S499, 1993.
39. Vukicevic, S., Luyten, F.P., and Reddi, A.H. Osteogenin inhibits proliferation and stimulates differentiation in mouse osteoblast-like cells (MC3T3-E1). Biochem Biophys Res Commun 166, 750, 1990.
40. Niikura, T., Hak, D.J., and Reddi, A.H. Global gene profiling reveals a downregulation of bmp gene expression in experimental atrophic nonunions compared to standard healing fractures. J Orthop Res 24, 1463, 2006.
41. Kloen, P., Di Paola, M., Borens, O., Richmond, J., Perino, G., Helfet, D.L., and Goumans, M.J. BMP Signaling components are expressed in human fracture callus. Bone 33, 362, 2003.
42. Kloen, P., Doty, S.B., Gordon, E., Rubel, I.F., Goumans, M.-J., and Helfet, D.L. Expression and activation of the BMP-signaling components in human fracture nonunions. J Bone Joint Surg Am 84, 1909, 2002.
43. Spector, J.A., Luchs, J.S., Mehrara, B.J., Greenwald, J.A., Smith, L.P., and Longaker, M.T. Expression of bone morphogenetic proteins during membranous bone healing. Plast Reconstr Surg 107, 124, 2001.
44. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., Aro, H., Atar, D., Bishay, M., Borner, M.G., Chiron, P., Choong, P., Cinats, J., Courtenay, B., Feibel, R., Geulette, B., Gravel, C., Haas, N., Raschke, M., Hammacher, E., van der Velde, D., Hardy, P., Holt, M., Josten, C., Ketterl, R.L., Lindeque, B., Lob, G., Mathevon, H., McCoy, G., Marsh, D., Miller, R., Munting, E., Oevre, S., Nordsletten, L., Patel, A., Pohl, A., Rennie, W., Reynders, P., Rommens, P.M., Rondia, J., Rossouw, W.C., Daneel, P.J., Ruff, S., Ruter, A., Santavirta, S., Schildhauer, T.A., Gekle, C., Schnettler, R., Segal, D., Seiler, H., Snowdowne, R.B., Stapert, J., Taglang, G., Verdonk, R., Vogels, L., Weckbach, A., Wentzensen, A., and Wisniewski, T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84, 2123, 2002.
45. Swiontkowski, M.F., Aro, H.T., Donell, S., Esterhai, J.L., Goulet, J., Jones, A., Kregor, P.J., Nordsletten, L., Paiement, G., and Patel, A. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88, 1258, 2006.
46. Lee, F.Y.-I., Sinicropi, S.M., Lee, F.S., Vitale, M.G., Roye, D.P., Jr., and Choi, I.H. Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7) a report of live cases. J Bone Joint Surg Am 88, 627, 2006.
47. Sampath, T.K., and Reddi, A.H. Distribution of bone inductive proteins in mineralized and demineralized extracellular matrix. Biochem Biophys Res Commun 119, 949, 1984.
48. Urist, M.R., Mikulski, A., and Lietze, A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A 76, 1828, 1979.
49. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., Zych, G.A., Calhoun, J.H., LaForte, A.J., and Yin, S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions: a prospective, randomized clinical trial comparing rhop-1 with fresh bone autograft. J Bone Joint Surg Am 83, S151, 2001.
50. Kanayama, M., Hashimoto, T., Shigenobu, K., Yamane, S., Bauer, T.W., and Togawa, D. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. Spine 31, 1067, 2005.
51. Haid, J.R.W., Branch, J.C.L., Alexander, J.T., and Burkus, J.K. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 4, 527, 2004.
52. Mummaneni, P., Pan, J., Haid, R., and Rodts, G. Contribution of recombinant human morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. J Neurosurg Spine 1, 19, 2004.
53. Vaccaro, A., Patel, T., Fischgrund, J., Anderson, D., Truumees, E., Herkowitz, H., Phillips, F., Hilibrand, A., and Albert, T. A 2-year follow-up pilot study evaluating the safety and efficacy of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 14, 623, 2005.
54. Jones, A.L., Bucholz, R.W., Bosse, M.J., Mirza, S.K., Lyon, T.R., Webb, L.X., Pollak, A.N., Golden, J.D., and Valentin-Opran, A. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects, a randomized, controlled trial. J Bone Joint Surg Am 88, 1431, 2006.
55. Friedman, C.D., Costantino, P.D., Takagi, S., and Chow, L.C. Bonesource™ hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res 43, 428, 1998.
56. Suzuki, O., Kamakura, S., Katagiri, T., Nakamura, M., Baohong, Z., Honda, Y., and Kamijo, R. Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials 27, 2671, 2006.
57. Manjubala, I., Sastry, T.P., and Kumar, R.V.S. Bone ingrowth induced by biphasic calcium phosphate ceramic in femoral defect of dogs. J Biomater Appl 19, 341, 2005.
58. Daculsi, G., and Layrolle, P. Osteoinductive properties of micro macroporous biphasic calcium phosphate bioceramics. Key Eng Mater 254-256, 1005, 2004.
59. Larsson, S., and Bauer, T.W. Use of injectable calcium phosphate cement for fracture fixation: a review. Clin Orthop Relat Res 395, 23, 2002.
60. Lee, Y.-M., Seol, Y.-J., Lini, Y.-T., Kim, S., Han, S.-B., Rhyu, I.-C., Baek, S.-H., Heo, S.-J., Choi, J.-Y., Klokkevold, P.R., and Chung, C.-P. Tissue-engineered growth of bone by marrow cell transplantation using porous calcium metaphosphate matrices. J Biomed Mater Res 54, 216, 2001.
61. Galois, L., and Mainard, D. Bone ingrowth into two porous ceramics with different pore sizes: an experimental study. Acta Orthop Belg 70, 598, 2004.
62. Del Real, R.P., Ooms, E., Wolke, J.G.C., Vallet-Regi, M., and Jansen, J.A. In vivo bone response to porous calcium phosphate cement. J Biomed Mater Res A 65, 30, 2003.
63. Gauthier, O., Bouler, J.-M., Aguado, E., Pilet, P., and Daculsi, G. Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials 19, 133, 1998.
64. Balasundaram, G., Sato, M., and Webster, T.J. Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials 27, 2798, 2006.
65. Moon, H.-J., Kim, K.-N., Kim, K.-M., Choi, S.-H., Kim, C.-K., Kim, K.-D., LeGeros, R., and Lee, Y.-K. Effect of calcium phosphate glass on bone formation in calvarial defects of sprague-dawley rats. J Mater Sci Mater Med 17, 807, 2006.
66. Manjubala, I., Sivakumar, M., Sureshkumar, R.V., and Sastry, T.P. Bioactivity and osseointegration study of calcium phosphate ceramic of different chemical composition. J Biomed Mater Res 63, 200, 2002.
67. Gosain, A.K., Song, L., Riordan, P., Amarante, M.T., Nagy, P.G., Wilson, C.R., Toth, J.M., and Ricci, J.L. A 1-year study of osteoinduction in hydroxyapatite-derived biomaterials in an adult sheep model: part I. Plast Reconstr Surg 109, 619, 2002.
68. Pekkarinen, T., Lindholm, T.S., Hietala, O., and Jalovaara, P. The effect of different mineral frames on ectopic bone formation in mouse hind leg muscles induced by native reindeer bone morphogenetic protein. Arch Orthop Trauma Surg 125, 10, 2005.
69. Le Huec, J.C., Schaeverbeke, T., Clement, D., Faber, J., and Le Rebeller, A. Influence of porosity on the mechanical resistance of hydroxyapatite ceramics under compressive stress. Biomaterials 16, 113, 1995.
70. Gisep, A., Kugler, S., Wahl, D., and Rahn, B. Mechanical characterisation of a bone defect model filled with ceramic cements. J Mater Sci Mater Med 15, 1065, 2004.
71. Zhang, Y., Xu, H., Takagi, S., and Chow, L. In-situ hardening hydroxyapatite-based scaffold for bone repair. J Mater Sci Mater Med 17, 437, 2006.
72. Xu, H.H.K., Weir, M.D., Burguera, E.F., and Fraser, A.M. Injectable and macroporous calcium phosphate cement scaffold. Biomaterials 27, 4279, 2006.
73. Ruhe, P.Q., Hedberg, E.L., Padron, N.T., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. Biocompatibility and degradation of poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites. J Biomed Mater Res A 74, 533, 2005.
74. Ruhe, P.Q., Hedberg-Dirk, E.L., Padron, N.T., Spauwen, P.H.M., Jansen, J.A., and Mikos, A.G. Porous poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 12, 789, 2006.
75. Khairoun, I., Billon, A., Daculsi, G., Merle, C., and Bouler, J.M. Improvement of porosity of a calcium phosphate cement by incorporation of biodegradable polymer microspheres. Key Eng Mater 284-286, 129, 2005.
76. Simon, J.C.G., Khatri, C.A., Wight, S.A., and Wang, F.W. Preliminary report on the biocompatibility of a moldable, resorbable, composite bone graft consisting of calcium phosphate cement and poly(lactide-co-glycolide) microspheres. J Orthop Res 20, 473, 2002.
77. Habraken, W.J.E.M., Wolfe, J.G.C., Mikos, A.G., and Jansen, J.A. Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed 17, 1057, 2006.
78. Linhart, W., Peters, F., Lehmann, W., Schwarz, K., Schilling, A.F., Amling, M., Rueger, J.M., and Epple, M. Biologically and chemically optimized composites of carbonated apatite and polyglycolide as bone substitution materials. J Biomed Mater Res 54, 162, 2001.
79. Yuan, H., Yang, Z., Li, Y., Zhang, X., De Bruijn, J.D., and De Groot, K. Osteoinduction by calcium phosphate biomaterials. J Mater Sci Mater Med 9, 723, 1998.
80. Gauthier, O., Muller, R., von Stechow, D., Lamy, B., Weiss, P., Bouler, J.-M., Aguado, E., and Daculsi, G. In vivo bone regeneration with injectable calcium phosphate biomaterial: a three-dimensional micro-computed tomographic, biomechanical and SEM study. Biomaterials 26, 5444, 2005.
81. Kroese-Deutman, H.C., Wolke, J.G., Spauwen, P.H. and Jansen, J.A. Closing capacity of cranial bone defects using porous calcium phosphate cement implants in a rabbit animal model. J Biomedi Mater Res A 79, 503, 2006.
82. Guobao, W., and Ma, P.X. Structure and properties of nanohydroxyapatite/ polymer composite scaffolds for bone tissue engineering. Biomaterials 25, 4749, 2004.
83. Kim, S.-S., Sun Park, M., Jeon, O., Yong Choi, C., and Kim, B.-S. Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 27, 1399, 2006.
84. Navarro, M., Ginebra, M.P., Planell, J.A., Zeppetelli, S., and Ambrosio, L. Development and cell response of a new biodegradable composite scaffold for guided bone regeneration. J Mater Sci Mater Med 15, 419, 2004.
85. LeGeros, R.Z. Properties of Osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 395, 81, 2002.
86. Weiss, D.D., Sachs, M.A., and Woodard, C.R. Calcium phosphate bone cements: a comprehensive review. J Long Term Eff Med Implants 13, 41, 2003.
87. Leventouri, T. Synthetic and biological hydroxyapatites: crystal structure questions. Biomaterials 27, 3339, 2006.
88. Yoshikawa, H., and Myoui, A. Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs 8, 131, 2005.
89. Rezwan, K., Chen, Q.Z., Blaker, J.J., and Boccaccini, A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27, 3413, 2006.
90. Weiner, S., and Addadi, L. Design strategies in mineralized biological materials. J Mater Chem 7, 689, 1997.
91. Boskey, A.L. Biomineralization: an overview. Connect Tissue Res 44, 5, 2003.
92. Muller, L., and Muller, F.A. Preparation of SBF with different content and its influence on the composition of biomimetic apatites. Acta Biomater 2, 181, 2006.
93. Kokubo, T., and Takadama, H. How useful Is SBF in predicting in vivo bone bioactivity? Biomaterials 27, 2907, 2006.
94. Cowan, C.M., Shi, Y.-Y., Aalami, O.O., Chou, Y.-F., Mari, C., Thomas, R., Quarto, N., Contag, C.H., Wu, B., and Longaker, M.T. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 22, 560, 2004.
95. Chen, Y., Mak, A.F.T., Li, J., Wang, M., and Shum, A.W.T. Formation of apatite on poly(alpha-hydroxy acid) in an accelerated biomimetic process. J Biomed Mater Res B Appl Biomater 73B, 68, 2005.
96. Chen, Y., Mak, A.F.T., Wang, M., and Li, J. Composite coating of bonelike apatite particles and collagen fibers on poly 1-lactic acid formed through an accelerated biomimetic coprecipitation process. J Biomed Mater Res B Appl Biomater 77B, 315, 2006.
97. Zainuddin, Hill, D.J.T., Chirila, T.V., Whittaker, A.K., and Kemp, A. Experimental calcification on HEMA-based hydrogels in the presence of albumin and a comparison to the in vivo calcification. Biomacromolecules 7, 1758, 2006.
98. Zeng, H., Chittur, K.K., and Lacefield, W.R. Analysis of bovine serum albumin adsorption on calcium phosphate and titanium surfaces. Biomalerials 20, 377, 1999.
99. Combes, C., and Rey, C. Adsorption of proteins and calcium phosphate materials bioactivity. Biomaterials 23, 2817, 2002.
100. Tanahashi, M., and Matsuda, T. Surface functional group dependence on apatite formation on self-assembled monolayers in a simulated body fluid. J Biomed Mater Res 34, 305, 1997.
101. Stephansson, S.N., Byers, B.A., and Garcia, A.J. Enhanced expression of the osteoblastic phenotype on substrates that modulate fibronectin conformation and integrin receptor binding. Biomaterials 23, 2527, 2002.
102. Keselowsky, B.G., Collard, D.M., and Garcia, A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci U S A 102, 5953, 2005.
103. Thorwarth, M., Schultze-Mosgau, S., Wehrhan, F., Kessler, P., Srour, S., Wiltfang, J.J., and Schlegel, K.A. Bioactivation of an anorganic bone matrix by P-15 peptide for the promotion of early bone formation. Biomaterials 26, 5648, 2005.
104. Filmon, R., Grizon, F., Basle, M.F., and Chappard, D. Effects of negatively charged groups (carboxymethyl) on the calcification of poly(2-hydroxyethyl methacrylate). Biomaterials 23, 3053, 2002.
105. Song, J., Malathong, V., and Bertozzi, C.R. Mineralization of synthetic polymer scaffolds: a bottom-up approach for the development of artificial bone. J Am Chem Soc 127, 3366, 2005.
106. Tan, J., and Saltzman, W.M. Micro-Engineered Biomineralized Materials for Bone Tissue Engineering. Houston, TX: IEEE, 2002, pp. 807-808.
107. Song, J., Saiz, E., and Bertozzi, C.R. Preparation of PHEMA-Cp composites with high interfacial adhesion via template-driven mineralization. J Europ Ceram Soc 23, 2905, 2003.
108. Oyane, A., Uchida, M., Choong, C., Triffitt, J., Jones, J., and Ito, A. Simple surface modification of poly(epsilon-caprolactone) for apatite deposition from simulated body fluid. Biomaterials 26, 2407, 2005.
109. Murphy, W.L., and Mooney, D.J. Bioinspired growth of crystalline carbonaie apatite on biodegradable polymer substrata. J Am Chem Soc 124, 1910, 2002.
110. Zhang, R., and Ma, P.X. Porous poly(L-lactic acid)/apatite composites created by biomimetic process. J Biomed Mater Res 45, 285, 1999.
111. Hunter, G.K., Poitras, M.S., Underhill, T.M., Grynpas, M.D., and Goldberg, H.A. Induction of collagen mineralization by a bone sialoprotein-decorin chimeric protein. J Biomed Mater Res 55, 496, 2001.
112. Sikavitsas, V.I., Bancroft, G.N., Lemoine, J.J., Liebschner, M.A.K., Dauner, M., and Mikos, A.G. Flow perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. Ann Biomed Eng 33, 63, 2005.
113. Gomes, M.E., Sikavitsas, V.I., Behravesh, E,. Reis, R.L., and Mikos, A.G. Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res A 67, 87, 2003.
114. Gomes, M.E., Bossano, C.M., Johnston, C.M., Reis, R.L., and Mikos, A.G. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng 12, 177, 2006.
115. Datta, N., Holtorf, H.L., Sikavitsas, V.I., Jansen, J.A., and Mikos, A.G. Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 26, 971, 2005.
116. Datta, N., Pham, Q.P., Sharma, U., Sikavitsas, V.I., Jansen, J.A., and Mikos, A.G. Tissue engineering special feature: in vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci U S A 103, 2488, 2006.
117. Meinel, L., Hofmann, S., Betz, O., Fajardo, R., Merkle, H.P., Langer, R., Evans, C.H., Vunjak-Novakovic, G., and Kaplan, D.L. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials 27, 4993, 2006.
118. Byers, B.A., and Garcia, A.J. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng 10, 1623, 2004.
119. Luppen, C.A., Ledere, N., Noli, T., Barski, A., Khokhar, A., Boskey, A.L., Smith, E., and Frenkel, B. Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem 278, 44995, 2003.
120. Stancu, I.C., Filmon, R., Grizon, F., Zaharia, C., Cincu, C., Basle, M.F., and Chappard, D. The in vivo calcification capacity of a copolymer, based on methacryloyloxyethyl phosphate, does not favor osteoconduction. J Biomed Mater Res A 69, 584, 2004.
121. Stancu, I.C., Filmon, R., Cincu, C., Marculeseu, B., Zaharia, C., Tourmen, Y., Basle, M.F., and Chappard, D. Synthesis of methacryloyloxyethyl phosphate copolymers and in vitro calcification capacity. Biomaterials 25, 205, 2004.
122. Yin, Y.J., Luo, X.Y., Cui, J.F., Wang, C.Y., Guo, X.M., and Yao, K.D. A study on biomineralization behavior of n-methylene phosphochitosan scaffolds. Macromol Biosci 4, 971, 2004.
123. Tan, J., Gemeinhart, R.A., Ma, M., and Mark Saltzman, W. Improved cell adhesion and proliferation on synthetic phosphonic acid-containing hydrogels. Biomaterials 26, 3663, 2005.
124. Gemeinhart, R.A., Bare, C.M., Haasch, R.T., and Gemeinhart, E.J. Osteoblast-like cell attachment to and calcification of novel phosphonate-containing polymeric substrates. J Biomed Mater Res A 78, 433, 2006.
125. Dalas, E., Kallitsis, J.K., and Koutsoukos, P.G. Crystallization of hydroxyapatite on polymers. Langmuir 7, 1822, 1991.
126. Wang, D.-A., Williams, C.G., Li, Q., Sharma, B., and Elisseeff, J.H. Synthesis and characterization of a novel degradable phosphate-containing hydrogel. Biomaterials 24, 3969, 2003.
127. Wang, D.-A., Williams, C.G., Yang, F., Cher, N., Lee, H., and Elisseeff, J.H. Bioresponsive phosphoester hydrogels for bone tissue engineering. Tissue Eng 11, 201, 2005.
128. Li, Q., Wang, J., Shahani, S., Sun, D.D.N., Sharma, B., Elisseeff, J.H., and Leong, K.W. Biodegradable and photocrosslinkable polyphosphoester hydrogel. Biomaterials 27, 1027, 2006.
129. Singh, A., Krogman, N.R., Sethuraman, S., Nair, L.S., Sturgeon, J.L., Brown, P.W., Laurencin, C.T., and Allcock, H.R. Effect of side group chemistry on the properties of biodegradable 1-alanine cosubstituted polyphosphazenes. Biomacromolecules 7, 914, 2006.
130. Nair, L.S., Lee, D.A., Bender, J.D., Barrett, E.W., Greish, Y.E., Brown, P.W., Allcock, H.R., and Laurencin, C.T. Synthesis, characterization, and osteocompatibility evaluation of novel alanine-based polyphosphazenes. J Biomed Mater Res A 76, 206, 2006.
131. Greish, Y.E., Bender, J.D., Lakshmi, S., Brown, P.W., Allcock, H.R., and Laurencin, C.T. Low temperature formation of hydroxyapatite-poly(alkyl oxybenzoate)phosphazene composites for biomedical applications. Biomaterials 26, 1, 2005.
132. Greish, Y.E., Bender, J.D., Lakshmi, S., Brown, P.W., Allcock, H.R., and Laurencin, C.T. Composite formation from hydroxyapatite with sodium and potassium salts of polyphosphazene. J Mater Sci Mater Med 16, 613, 2005.
133. Pederson, A.W., Ruberti, J.W., and Messersmith, P.B. Thermal assembly of a biomimetic mineral/collagen composite. Biomaterials 24, 4881, 2003.
134. Kaneko, T., Ogomi, D., Mitsugi, R., Serizawa, T., and Akashi, M. Mechanically drawn hydrogels uniaxially orient hydroxyapatite crystals and cell extension. Chem Mater 16, 5596, 2004.
135. Maeno, S., Niki, Y., Matsumoto, H., Morioka, H., Yatabe, T., Funayama, A., Toyama, Y., Taguchi, T., and Tanaka, J. The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture. Biomaterials 26, 4847, 2005.
136. Salgado, A.J., Figueiredo, J.E., Coutinho, O.P., and Reis, R.L. Biological response to pre-mineralized starch based scaffolds for bone tissue engineering. J Mater Sci Mater Med 16, 267, 2005.
137. Hu, Y., Zhang, C., Zhang, S., Xiong, Z., and Xu, J. Development of a porous poly(L-lactic acid)/ hydroxyapatite/ collagen scaffold as a BMP delivery system and its use in healing canine segmental bone defect. J Biomed Mater Res A 67, 591, 2003.
138. Peter, S.J., Kim, P., Yasko, A.W., Yaszemski, M.J., and Mikos, A. Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res 44, 314, 1999.
139. Yokoyama, A., Gelinsky, M., Kawasaki, T., Kohgo, T., Konig, U., Pompe, W., and Watari, F. Biomimetic porous scaffolds with high elasticity made from mineralized collagen - an animal study. J Biomed Mater Res B Appl Biomater 75, 464, 2005.
140. Hossainy, S.F.A., and Hubbell, J.A. Molecular weight dependence of calcification of polyethylene glycol hydrogels. Biomaterials 15, 921, 1994.
141. Ahmad, M., McCarthy, M., and Gronowicz, G. In vitro model for mineralization of human osteoblast-like cells on implant materials. Biomaterials 20, 211, 1999.
142. Coelho, M.J., and Fernandes, M.H. Human bone cell cultures in biocompatibility testing. part ii: effect of ascorbic acid, beta- glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21, 1095, 2000.
143. Zhu, X.-L., Ganss, B., Goldberg, H.A., and Sodek, J. Synthesis and processing of bone sialoproteins during de novo bone formation in vitro. Biochem Cell Biol 79, 737, 2001.
144. Bielby, R.C., Boccaccini, A.R., Polak, J.M., and Buttery, L.D.K. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 10, 1518, 2004.
145. Jayasuriya, A.C., Assad, M., Jayatissa, A.H., and Ebraheim, N.A. Dissolution behavior of biomimetic minerals on 3D PLGA scaffold. Surface Coatings Technol 200, 6336, 2006.
146. Ruhe, P.Q., Boerman, O.C., Russel, F.G., Spauwen, P.H., Mikos, A.G., and Jansen, J.A. Controlled release of rhBMP-2 loaded poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release 106, 162, 2005.
147. Schnieders, J., Gbureck, U., Thull, R., and Kissel, T. Controlled release of gentamicin from calcium phosphate - poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 27, 4239, 2006.
148. Murphy, W.L., Peters, M.C., Kohn, D.H., and Mooney, D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21, 2521, 2000.
149. Oyane, A., Yokoyama, Y., Uchida, M., and Ito, A. The formation of an antibacterial agent-apatite composite coating on a polymer surface using a metastable calcium phosphate solution. Biomaterials 27, 3295, 2006.
150. Azevedo, H.S., Leonor, I.B., Alves, C.M., and Reis, R.L. Incorporation of proteins and enzymes at different stages of the preparation of calcium phosphate coatings on a degradable substrate by a biomimetic methodology. Mater Sci Eng C 25, 169, 2005.
151. Kohn, D.H., Luong, L.N., Sun Ig, H., Patel, R.J., and Outslay, M.E. Spatial control of protein within biomimetically nucleated mineral. Biomaterials 27, 1175, 2006.
152. Eom, G.T., Oh, S.Y., and Park, T.G. In situ thermal gelation of water-soluble poly(N-isopropylacrylamide-co-vinylphosphonic acid). J Appl Polym Sci 70, 1947, 1998.
153. Wang, J., Mao, H.Q., and Leong, K.W. A novel biodegradable gene carrier based on polyphosphoester. J Am Chem Soc 123, 9480, 2001.